Search Results - Joachim Fruebis

  • Showing 1 - 11 results of 11
Refine Results
  1. 1
    Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

    Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice by Joachim Fruebis

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Evidence for a concerted reaction between lipid hydroperoxides and polypeptides.

    Evidence for a concerted reaction between lipid hydroperoxides and polypeptides. by Joachim Fruebis, Srinivasan Parthasarathy, Daniel Steinberg

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Effect of Probucol Treatment on Gene Expression of VCAM-1, MCP-1, and M-CSF in the Aortic Wall of LDL Receptor–Deficient Rabbits During Early Atherogenesis

    Effect of Probucol Treatment on Gene Expression of VCAM-1, MCP-1, and M-CSF in the Aortic Wall of LDL Receptor–Deficient Rabbits During Early Atherogenesis by Joachim Fruebis, V. González, Mercedes Silvestre, Wulf Palinski

    Published 1997
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

    Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors. by Sylvie Picard, Srinivasan Parthasarathy, Joachim Fruebis, Joseph L. Witztum

    Published 1992
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.

    A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits. by Joachim Fruebis, Daniel Steinberg, H. A. Dresel, T E Carew

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

    Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice by Joachim Fruebis, Tsu‐Shuen Tsao, Sandrine Javorschi, Dana Ebbets-Reed, Mary Erickson, Frances T. Yen, Bernard E. Bihain, Harvey F. Lodish

    Published 2001
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen

    C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen by Gerald Lasser, Prasenjit Guchhait, Jeff L. Ellsworth, Paul O. Sheppard, Ken Lewis, Paul D. Bishop, Miguel A. Crúz, José A. López, Joachim Fruebis

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study

    Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study by Beatrice Nolan, Johnny Mahlangu, Ingrid Pabinger, Guy Young, Barbara A. Konkle, Chris Barnes, Keiji Nogami, Elena Santagostino, John Pasi, Liane Khoo, Bent Winding, Huixing Yuan, Joachim Fruebis, Dan Rudin, Johannes Oldenburg

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A

    BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A by Barbara A. Konkle, Amy D. Shapiro, Doris Quon, Janice M. Staber, Roshni Kulkarni, Margaret V. Ragni, Ekta Seth Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda, Dan Rudin, Joachim Fruebis, Craig C Benson

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extension study

    Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extensio... by John Pasi, Kathelijn Fischer, Margaret V. Ragni, Roshni Kulkarni, Margareth C. Ozelo, Johnny Mahlangu, Amy D. Shapiro, Stephanie P’ng, Hérvè Chambost, Beatrice Nolan, Carolyn M. Bennett, Tadashi Matsushita, Bent Winding, Joachim Fruebis, Huixing Yuan, Dan Rudin, Johannes Oldenburg

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Sutimlimab in Cold Agglutinin Disease

    Sutimlimab in Cold Agglutinin Disease by Alexander Röth, Wilma Barcellini, Shirley D’Sa, Yoshitaka Miyakawa, Catherine M. Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Joachim Fruebis, Xiaoyu Jiang, Stella Lin, Caroline Reuter, Jaime Morales‐Arias, William E. Hobbs, Sigbjørn Berentsen

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: